3E Bioventures Capital

About The Fund

3E Bioventures Capital is a venture capital firm that specializes in growth and early-stage investments within the life sciences sector. With a geographical focus on Beijing and Shanghai, China, they channel capital into ventures that are positioned in the drug, device, diagnostics, healthcare IT, and medical services industries. Their investment strategy encompasses a broad range of areas, including BioTech, HealthTech, Medical Devices, Healthcare and Wellness, Investment Management, Life Science, Mobile Technologies, and Pharmaceuticals. 3E Bioventures targets investment opportunities with a minimum threshold of $100,000 and a maximum limit of $5,000,000, with a preferred 'sweet spot' investment size of approximately $1,500,000. Their prominent investment stages include Early-Stage, Seed, Series A, and Series B funding rounds. The firm's approach is deeply rooted in leveraging their scientific expertise, aiming for streamlined and efficient processes and unwavering execution to foster the growth of health innovators. Founded in 2015, the firm seeks to make transformative contributions by working closely with companies and research institutions at the cutting-edge intersection of biology and technology, especially those that introduce new drugs, new modalities, and drug discovery platforms. The underlying essence of their mission, 'Expertise, Efficiency, Execution,' is not only reflected in their name but also reinforces their commitment to being an entrepreneur-friendly firm, focusing intensely on the development of solutions addressing significant unmet medical needs. At 3E Bioventures, they believe that their entrepreneurial partners' success is their best reward, indicating a deeply collaborative and supportive ethos towards the ventures they invest in.